GlassScriptPhysician profile
Rakesh Doshetty
NPI 1174906515
$10,177.90
in general payments reported to CMS, 2019-2025
29 companies · $5,385 in 2025
The $5,385 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $346 · 2021: $635 · 2022: $697 · 2023: $440 · 2024: $2,155 · 2025: $5,385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,628 · Travel and Lodging: $3,280 · Education: $71.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,628.16 |
| Travel and Lodging | $3,280.16 |
| Education | $71.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,384.36 | 2024-2025 | Indigo System |
| Abbott Laboratories | $2,345.26 | 2021-2025 | Perclose Proglide, Xience Skypoint, Perclose Prostyle |
| Abiomed | $1,733.48 | 2021-2025 | Impella |
| Shockwave Medical, INC | $634.15 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $519.66 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $358.44 | 2020-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $312.01 | 2019-2025 | Brilinta, Wainua, Farxiga |
| Pfizer INC. | $229.89 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $229.69 | 2020-2025 | |
| Boston Scientific Corporation | $211.68 | 2024-2025 | Watchman Flx |
| Merck Sharp & Dohme LLC | $198.39 | 2021-2025 | Verquvo, Capvaxive |
| Medtronic, INC. | $129.76 | 2021-2025 | Claria Mri Quad Crt-D Surescan, Micra, Azure Xt Dr Mri Surescan |
| Teleflex LLC | $121.07 | 2025 | Manta |
| Cardiovascular Systems INC. | $116.98 | 2019 | |
| Stryker Corporation | $99.41 | 2025 | Clottriever Bold Catheter, Artix Mt |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $75.49 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $71.45 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.03 | 2022-2025 | Jardiance |
| Cleerly, INC. | $64.11 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Kestra Medical Technology Services, INC. | $46.09 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $41.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.78 | 2025 | |
| Corcept Therapeutics | $29.62 | 2025 | Korlym |
| Cook Medical LLC | $28.33 | 2024 | Icast Covered Stent System, 6mmx22mmx120cm |
| Astellas Pharma US INC | $22.75 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $21.70 | 2022 | |
| Vital Connect, INC | $17.34 | 2025 | Vitalpatch Rtm |
| Argon Medical Devices, INC. | $16.84 | 2025 | Clot Management |
| Esperion Therapeutics, INC. | $16.11 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Doshetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.